Balchem Corporation
BCPC
$175.69
-$0.47-0.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 240.00M | 239.94M | 234.08M | 239.66M | 228.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 240.00M | 239.94M | 234.08M | 239.66M | 228.70M |
| Cost of Revenue | 153.67M | 154.58M | 151.09M | 158.15M | 153.71M |
| Gross Profit | 86.34M | 85.36M | 82.99M | 81.51M | 74.99M |
| SG&A Expenses | 33.79M | 32.52M | 33.34M | 35.30M | 42.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 191.96M | 191.43M | 188.28M | 197.54M | 200.45M |
| Operating Income | 48.04M | 48.51M | 45.80M | 42.12M | 28.25M |
| Income Before Tax | 44.48M | 43.89M | 41.23M | 36.85M | 33.27M |
| Income Tax Expenses | 10.90M | 10.06M | 9.16M | 7.86M | 6.62M |
| Earnings from Continuing Operations | 33.58M | 33.84M | 32.07M | 28.99M | 26.65M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.58M | 33.84M | 32.07M | 28.99M | 26.65M |
| EBIT | 48.04M | 48.51M | 45.80M | 42.12M | 28.25M |
| EBITDA | 58.87M | 59.34M | 58.23M | 55.71M | 42.24M |
| EPS Basic | 1.03 | 1.05 | 0.99 | 0.90 | 0.82 |
| Normalized Basic EPS | 0.87 | 0.86 | 0.80 | 0.72 | 0.45 |
| EPS Diluted | 1.03 | 1.03 | 0.98 | 0.89 | 0.82 |
| Normalized Diluted EPS | 0.87 | 0.85 | 0.79 | 0.71 | 0.45 |
| Average Basic Shares Outstanding | 32.55M | 32.37M | 32.31M | 32.25M | 32.48M |
| Average Diluted Shares Outstanding | 32.55M | 32.78M | 32.65M | 32.63M | 32.48M |
| Dividend Per Share | 0.87 | -- | -- | -- | 0.79 |
| Payout Ratio | 0.01% | 0.01% | 0.04% | 88.16% | 0.00% |
